Metabolic & Cardiometabolic
regular nut consumption improves cognition
In plain terms: Do nuts benefit cognition and brain health?
Not clearly — nuts are healthy, but the cognition evidence is genuinely mixed: the main 2-year walnut RCT was null overall, and the positive signals are small, population-specific, or confounded with a whole Mediterranean diet.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
Nuts are healthy food, but the cognition case is weak: a meta-analysis of five randomised trials in 928 adults found no effect, and the Mediterranean-diet trial that showed benefit cannot isolate nuts from the rest of the diet. A four-week crossover in 79 healthy adults was mixed, so this is unsettled rather than supported.
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Martínez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvadó J, San Julián B, Sanchez-Tainta A, Ros E, Valls-Pedret C, Martinez-Gonzalez MÁ 2013 · J Neurol Neurosurg Psychiatry | RCT | supports | moderate | Mediterranean diet supplemented with nuts improved cognition versus low-fat control, though the nut effect is confounded with the whole-diet pattern. |
| Goni L, Fernández-Matarrubia M, Romanos-Nanclares A, Razquin C, Ruiz-Canela M, Martínez-González MÁ, Toledo E 2021 · Br J Nutr | observational | mixed | moderate | Nut-rich lignan intake associated with more favorable cognitive change, but total polyphenol intake showed no overall cognitive association. |
| Haskell-Ramsay CF, Dodd FL, Smith D, Cuthbertson L, Nelson A, Lodge JK, Jackson PA 2023 · The Journal of nutrition | RCT | mixed | moderate | 4-week placebo-controlled, double-blind, randomized crossover trial in 79 healthy adults (18-49y), 30 g/d mixed tree nuts vs placebo; nut consumption improved picture-recognition accuracy (94.5% vs 92.2%, P=0.019) and response speed (757ms |
| Moabedi M, Aliakbari M, Erfanian S, Jibril AT, Milajerdi A 2024 · Front Nutr | meta-analysis | tested-null | low | Meta-analysis of 5 RCTs (928 adults; 6 effect sizes - almond trial split into two dose arms): nuts vs control on cognition scores, SMD 0.27 (95% CI -0.65 to 1.19), p=0.57, I2=94%. Underpowered trend: the point estimate favours nuts but the interval includes zero, with extreme heterogeneity (sensitivity range of summary estimates -0.86 to 1.49); placebo-controlled trials only SMD 0.17 (-1.08 to 1.41). Subgroup of trials <=6 months significant. Egger p=0.692. Pooled trials include WAHA (walnuts, 2 y), which also votes separately on this claim. |
| Cahoon D, Shertukde SP, Avendano EE, Tanprasertsuk J, Scott TM, Johnson EJ, Chung M, Nirmala N 2021 · Ann Med | meta-analysis | mixed | moderate | Systematic review found walnut intake associated with some cognitive benefits but evidence was limited and inconsistent. |
| Ros E, Singh A, O'Keefe JH 2021 · Nutrients | observational | supports | low | Review argues nut bioactives plausibly benefit cognition and mood via anti-inflammatory and antioxidant pathways, a mechanistic rather than outcome claim. |
| Godos J, Giampieri F, Frias-Toral E, Zambrano-Villacres R, Vistorte AOR, Yélamos Torres V, Battino M, Galvano F, Castellano S, Grosso G 2025 · Nutrients | observational | supports | low | Cross-sectional study of 883 Italian adults >50y using FFQ and Short Portable Mental Status Questionnaire; higher total nut intake (39.7 g/d vs 4.3 g/d) associated with lower prevalence of impaired cognitive status (OR=0.35, 95% CI 0.15-0.8 |
| Sala-Vila A, Valls-Pedret C, Rajaram S, Coll-Padrós N, Cofán M, Serra-Mir M, Pérez-Heras AM, Roth I, Freitas-Simoes TM, Doménech M, Calvo C, López-Illamola A, Bitok E, Buxton NK, Huey L, Arechiga A, Oda K, Lee GJ, Corella D, Vaqué-Alcázar L, Sala-Llonch R, Bartrés-Faz D, Sabaté J, Ros E 2020 · Am J Clin Nutr | RCT | contradicts | high | WAHA 2020 two-centre RCT, 708 cognitively healthy elders (63-79 y), walnuts ~15% energy (30-60 g/d) vs abstention for 2 y: mITT (n = 657) 'uncovered no between-group differences in the global cognitive composite, with mean changes of -0.072 (95% CI: -0.100, -0.043) in the walnut diet group and -0.086 (95% CI: -0.115, -0.057) in the control diet group (P = 0.491).' Primary null on a directional claim = contradicts. Post hoc Barcelona subgroup P = 0.040 (unadjusted) is exploratory. Walnuts only. |
| Chen X, Liu Z, Sachdev PS, Kochan NA, O'Leary F, Brodaty H 2021 · J Nutr Health Aging | observational | supports | low | Dietary patterns showed some association with cognition in older adults but nut-specific effects were not clearly isolated. |
| Katzman EW, Nielsen SJ 2021 · J Prev Alzheimers Dis | observational | supports | low | Community-dwelling older adults consuming peanuts/peanut butter showed better cognitive function on some measures. |
| Bizzozero-Peroni B, Díaz-Goñi V, Beneit N, Oliveira A, Jiménez-López E, Martínez-Vizcaíno V, Mesas AE 2025 · GeroScience | observational | supports | high | UK Biobank prospective cohort, 50,386 adults followed 7.1 years; daily nut consumption associated with 12% lower risk of all-cause dementia (HR=0.88, 95% CI 0.77-0.99) vs no consumption, adjusted for sociodemographic/lifestyle confounders. |
| Nishi SK, Sala-Vila A, Julvez J, Sabaté J, Ros E 2023 · Nutrients | observational | mixed | low | Narrative review of epidemiological, clinical-trial, and mechanistic evidence on nut consumption and cognition across the lifespan; concludes evidence is 'limited and inconclusive' though suggestive of a possible protective role, especially |
| Martínez-Lapiscina EH, Galbete C, Corella D, Toledo E, Buil-Cosiales P, Salas-Salvado J, Ros E, Martinez-Gonzalez MA 2014 · Genes Nutr | RCT | mixed | low | MedDiet-with-nuts cognitive benefit was modulated by genotype, indicating effects are conditional rather than uniform. |
| Theodore LE, Kellow NJ, McNeil EA, Close EO, Coad EG, Cardoso BR 2021 · Adv Nutr | observational | mixed | moderate | Systematic review found inconsistent overall evidence but a more favorable signal in higher-risk populations and for walnuts specifically. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.